These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28976216)

  • 21. New approaches for identifying and testing potential new anti-asthma agents.
    Licari A; Castagnoli R; Brambilla I; Marseglia A; Tosca MA; Marseglia GL; Ciprandi G
    Expert Opin Drug Discov; 2018 Jan; 13(1):51-63. PubMed ID: 29077521
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moving towards precision care for childhood asthma.
    Mokhallati N; Guilbert TW
    Curr Opin Pediatr; 2016 Jun; 28(3):331-8. PubMed ID: 27093356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of asthma-COPD overlap syndrome.
    Joo H; Han D; Lee JH; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():697-703. PubMed ID: 28260876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of T2 inflammation biomarkers in severe asthma.
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2016 Jan; 22(1):59-68. PubMed ID: 26574724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma?
    Tsujino I; Nishimura M; Kamachi A; Makita H; Munakata M; Miyamoto K; Kawakami Y
    Respiration; 2000; 67(6):645-51. PubMed ID: 11124647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
    Newby C; Agbetile J; Hargadon B; Monteiro W; Green R; Pavord I; Brightling C; Siddiqui S
    J Allergy Clin Immunol; 2014 Aug; 134(2):287-94. PubMed ID: 24928647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic obstructive pulmonary disease phenotypes and the related characteristics of treatment response].
    Pan MM; Sun TY; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Apr; 36(4):293-6. PubMed ID: 23945345
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function.
    Brooks CR; Van Dalen CJ; Harding E; Hermans IF; Douwes J
    BMC Pulm Med; 2017 Dec; 17(1):169. PubMed ID: 29202821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asthma phenotypes today.
    Cottini M; Asero R
    Eur Ann Allergy Clin Immunol; 2013 Feb; 45(1):17-24. PubMed ID: 23678555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent airflow obstruction in patients with asthma: Characteristics of a distinct clinical phenotype.
    Konstantellou E; Papaioannou AI; Loukides S; Patentalakis G; Papaporfyriou A; Hillas G; Papiris S; Koulouris N; Bakakos P; Kostikas K
    Respir Med; 2015 Nov; 109(11):1404-9. PubMed ID: 26412805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severe asthma: can we do better?].
    Chung KF; Blanc FX
    Rev Mal Respir; 2003 Sep; 20(4):495-500. PubMed ID: 14528150
    [No Abstract]   [Full Text] [Related]  

  • 32. Outpatient Management for Acute Exacerbations of Obstructive Lung Diseases.
    Marsh B; Drake MG
    Med Clin North Am; 2017 May; 101(3):537-551. PubMed ID: 28372712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From diagnosis of asthma to chronic disease].
    Taytard A
    Rev Prat; 2001 Mar; 51(5):483-8. PubMed ID: 11345555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe asthma: epidemiology, burden of illness, and heterogeneity.
    Lang DM
    Allergy Asthma Proc; 2015; 36(6):418-24. PubMed ID: 26534747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
    Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
    BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
    Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.
    Prime D; de Backer W; Hamilton M; Cahn A; Preece A; Kelleher D; Baines A; Moore A; Brealey N; Moynihan J
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):486-97. PubMed ID: 26372467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of asthma: new approaches to establishing control.
    Sarver N; Murphy K
    J Am Acad Nurse Pract; 2009 Jan; 21(1):54-65. PubMed ID: 19125896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.